MST1 and diabetes mellitus: Additionally, IHMT-MST1-39, a MST1 inhibitor, has demonstrated significant anti-apoptotic effects, effectively enhancing the survival of pancreatic β-cells under diabetes-inducing conditions and improving the viability of primary islets in ex vivo disease models [119].